Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Fallopian Tube Neoplasms × olaparib × Clear all

Phase

Status

Active not recruiting 9 Recruiting 7 Completed 3 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 12 Endometrial Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Neoplasms 3 Breast Neoplasms 3 Uterine Neoplasms 2 Small Cell Lung Carcinoma 2 Recurrence 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Ovarian Diseases 1 Neuroendocrine Tumors 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Mesothelioma 1 Laryngeal Neoplasms 1 Kenny-Caffey syndrome, Type 1 1 Hyperglycemia 1 High Grade Serous Ovarian Cancer 1 Head and Neck Neoplasms 1 Genital Neoplasms, Female 1

Interventions

Paclitaxel 16 Carboplatin 14 Bevacizumab 5 Taxes 3 Hyperthermic Intraperitoneal Chemotherapy 3 Gemcitabine 3 Cisplatin 3 Chemotherapy, Adjuvant 3 pembrolizumab 2 oregovomab 2 fluzoparib 2 Topotecan 2 ST 1481 2 Neoadjuvant Therapy 2 Methods 2 Immunohistochemistry 2 Ifosfamide 2 Gene Expression Profiling 2 Filgrastim 2 Educational Status 2 Early Intervention, Educational 2 Cytoreduction Surgical Procedures 2 Amplified Fragment Length Polymorphism Analysis 2 rucaparib 1 paclitaxel poliglumex 1 olaparib 1 niraparib 1 navicixizumab 1 mirvetuximab soravtansine 1 liposomal doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02489006 2024-01-17

NEO

University Health Network, Toronto

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡